Skip to main content

ORIGINAL RESEARCH article

Front. Pharmacol.
Sec. Gastrointestinal and Hepatic Pharmacology
Volume 15 - 2024 | doi: 10.3389/fphar.2024.1448863
This article is part of the Research Topic Advances in the Treatment of Acute Severe Ulcerative Colitis View all articles

p-hydroxy benzaldehyde attenuates intestinal epithelial barrier dysfunction caused by colitis via activating the HNF-1β/SLC26A3 pathway

Provisionally accepted
Meng Liu Meng Liu 1*Yuhui Wang Yuhui Wang 1Xiaotian Xu Xiaotian Xu 1*Guoqiang Guan Guoqiang Guan 1*Shu Zhang Shu Zhang 1*Shengnan Zhu Shengnan Zhu 1*Yang Liu Yang Liu 1*Yi Zhun ZHU Yi Zhun ZHU 2*Xiaoqun Duan Xiaoqun Duan 1*
  • 1 Guilin Medical University, Guilin, China
  • 2 Macau University of Science and Technology, Taipa, Macao, Macao, SAR China

The final, formatted version of the article will be published soon.

    Intestinal epithelial barrier dysfunction is intricately linked to the pathogenesis of ulcerative colitis (UC). Dietary interventions that bolster intestinal epithelial barrier function can effectively thwart UC onset. Our prior research revealed that p-Hydroxy benzaldehyde (HD), a phenolic compound from Nostoc commune (an edible cyanobacterium), markedly upregulated the expression of E-cadherin, a pivotal protein in intestinal mucosa, thereby mitigating mucosal damage in mice afflicted with dextran sulfate sodium (DSS)-induced colitis. Nevertheless, the precise molecular mechanisms underpinning HD's ameliorative effects on intestinal epithelial barrier dysfunction remain elusive. This study elucidates HD's role in forestalling intestinal epithelial barrier disruption under colitis conditions. Mechanistic investigations revealed that HD fortifies TJs and AJs expression via the HNF-1β/SLC26A3 pathway, thus preserving the lower intestinal epithelial barrier's integrity in UC. In recent years, several natural products have been recognized for their unique multi-target actions, good tolerability and low-cost attracting much attention (Zhou, Wang, & Yan, 2023) . Natural products are abundant in nature and generate numerous structurally diverse secondary metabolites, including a large number of small molecule compounds with anti-inflammatory activity (Zhou et al., 2023). Nostoc commune, a cyanobacterium vegetable with significant nutritional benefits, is recognized for its anticancer, anti-inflammatory, and antimicrobial attributes (Z. Li & Guo, 2018) . Our previous research has shown that p-hydroxy benzaldehyde (HD), a phenolic compound from Nostoc commune, can relieve colitis, reduce inflammation, and increase E-cadherin expression (Xu, Wei, Yang, Liu, & Duan, 2021) . Yet, the exact molecular mechanisms through which HD ameliorates intestinal epithelial barrier dysfunction remain to be elucidated. Studies have shown that E-cadherin is closely related to mucosal barrier function, mucin 2 (MUC2) and goblet cell number. E-cadherin loss interferes with goblet cell maturation and migration (Schneider, Dahlhoff, Horst, Hirschi, & Kolligs, 2010) , reducing the number of goblet cells, thereby reducing the secretion of mucin MUC2 and damaging mucosal barrier function (Y. Liu et al., 2023) . Based on these findings, this study aims to elucidate HD's protective effects on the intestinal epithelial barrier and its mechanisms by developing in vitro and in vivo models of intestinal barrier injury, thereby assessing its therapeutic potential for UC.

    Keywords: ulcerative colitis, p-hydroxy benzaldehyde, Intestinal epithelial barrier dysfunction, HNF-1β, SLC26A3

    Received: 14 Jun 2024; Accepted: 04 Nov 2024.

    Copyright: © 2024 Liu, Wang, Xu, Guan, Zhang, Zhu, Liu, ZHU and Duan. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence:
    Meng Liu, Guilin Medical University, Guilin, China
    Xiaotian Xu, Guilin Medical University, Guilin, China
    Guoqiang Guan, Guilin Medical University, Guilin, China
    Shu Zhang, Guilin Medical University, Guilin, China
    Shengnan Zhu, Guilin Medical University, Guilin, China
    Yang Liu, Guilin Medical University, Guilin, China
    Yi Zhun ZHU, Macau University of Science and Technology, Taipa, Macao, Macao, SAR China
    Xiaoqun Duan, Guilin Medical University, Guilin, China

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.